Dreavent, Inc.
VC · Boston (United States)
VC
Seed
Series A
Healthcare
Sign up free to access full profile and submit your pitch.
About
Dreavent is a venture capital firm focused on the Boston biotech ecosystem, investing in emerging U.S. biopharma companies specializing in Oncology, Neurology, Cardiovascular, and Immunology.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Min. Ticket Size
$10,000,000
Max. Ticket Size
$50,000,000
Investment Stage
Seed
Series A
Series B
Series C
Focus Areas
Countries
Regions
North America
Similar Investors
Featured in